EJNMMI Radiopharmacy and Chemistry is a new journal within the EJNMMI family to publish research in the field of new imaging and radionuclide based therapeutic agents that can be applied in nuclear medicine and molecular imaging. There is a great need for better and more specific imaging agents for better diagnosis and understanding of disease. This will finally enable improvement of patient treatment. Combination of different molecular imaging modalities to obtain the optimal diagnostic information will be boostered by the development of hybrid imaging probes. The number of applications of radionuclide therapy is increasing and more effective radiotherapeutic agents are urgently needed. Thus it can be concluded that radiopharmacy and radiochemistry are very essential for the development of nuclear medicine and molecular imaging and for its position in personalized medicine.

This new journal provides an ideal platform for chemists, pharmacists and basic scientists to promote science, but also to exchange opinions and to provide updates on developments that have effect on availability of imaging agents for the clinic such as regulatory aspects. By accepting original research articles, review papers, guidelines on application of imaging or radionuclide therapy agents, editorials, and letters to the editor I hope to establish a unique platform for our community.